Press Releases

Oct
2
2020

AcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future

AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification of patients’ own stem cells for further use in clinical applications

Read More
Sep
4
2020

AcouSort participates in a new important CAMP project

AcouSort will participate in yet another CAMP project. The goal is to develop a GMP-approved production of stem cells. Among other participants in the project are the Region Örebro län,

Read More
Aug
26
2020

Interim report Q2 2020

On August 26, AcouSort released its interim report for the second quarter of 2020. The report can be found in Swedish and English here: AcouSort Interim report Q2 2020. For all

Read More
Jul
1
2020

AcouSort signs agreement with Korean life science company

AcouSort has signed a cooperation agreement with another Korean life science company. The agreement concerns the evaluation of the AcouTrap technology to develop a diagnostic test for the detection of

Read More
Jun
29
2020

AcouSort successfully completes product development assignment for Instrumentation Laboratory

AcouSort and the world-leading medical technology company Instrumentation Laboratory Inc. (IL) have an on-going collaboration. AcouSort has now successfully completed the second project in the collaboration agreement from 2018. –

Read More
Jun
17
2020

AcouSort launches a directed share issue valued SEK 11.7 million to complete development of the company’s first series of OEM-manufactured modules and the production line for these

AcouSort has today decided, for strategic reasons, to carry out a directed share issue totaling SEK 11.7 million to a consortium of existing shareholders and new targeted investors. Thus, the

Read More
Jun
15
2020

AcouSort receives ISO 13485 certification – an important step towards commercialization

During spring, AcouSort has worked on certifying the company’s quality management system. The auditing process has now been completed without deviations, which means that the company is ISO 13485 certified.

Read More
Jun
10
2020

AcouSort receives EUR 300 000 in Eurostars grant to develop stem cell therapy equipment

AcouSort AB (publ) (“AcouSort”) receives funding from Vinnova through Eurostars for the Blue4Therapy project. The aim of the project is to develop a system for the establishment of adipose tissue

Read More
Jun
9
2020

Report from Annual General Meeting

Today AcouSort has conducted its Annual General Meeting. The communique in Swedish may be found here: Kommuniké från årsstämma i AcouSort.

Read More
May
29
2020

AcouSort signs agreement with University of Kentucky for AcouTrap evaluation

AcouSort has signed an agreement with the University of Kentucky for an evaluation of the AcouTrap system. The system will be used in research projects related to the role of

Read More